Drugs Made In America Acquisition Corp. Units (DMAAU) Revenue Analysis | Historical Sales Growth & Trends - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Drugs Made In America Acq...

    NASDAQ: DMAAU · Real-Time Price · USD
    10.36
    -0.23 (-2.17%)
    At close: Sep 26, 2025, 11:44 AM
    10.36
    0.00%
    Pre-market: Sep 26, 2025, 11:44 AM EDT

    Drugs Made In America Acquisition Units Revenue

    Drugs Made In America Acquisition Units reported an annual revenue of $0, reflecting a undefined% growth. For the quarter ending June 30, 2025, Drugs Made In America Acquisition Units generated $0 in revenue.
    Revenue (ttm)
    n/a
    Revenue Growth
    n/a
    Price / Sales Ratio
    n/a
    Revenue / Employee
    n/a
    Employees
    n/a
    Market Cap
    242.73M

    Revenue Chart

    History

    Fiscal Year End Revenue % Change
    Dec 31, 2024 0 n/a
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist